Mechanisms and regulation of protein-mediated cellular fatty acid uptake: Molecular, biochemical, and physiological evidence

Physiology

Volumn 22, Issue 1, 2007, Pages 15-28

  Bonen, Arend ^a   Chabowski, Adrian ^b   Luiken, Joost J F P ^c   Glatz, Jan F C ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34447533581     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiologyonline.2007.22.1.15     Document Type: Article

References (145)

1. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grimaldi P. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665-17668, 1993.
2. Abumrad NA, Perkins RC, Park JH, Park CR. Mechanism of long chain fatty acid permeation in the isolated adipocyte. J Biol Chem 256: 9183-9191, 1981.
3. Bastie CC, Hajri T, Drover VA, Grimaldi PA, Abumrad NA. CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. Diabetes 53: 2209-2216, 2004.
4. Benton CR, Koonen D P, Calles-Escandon J, Tandon NN, Glatz JFC, Luiken JJFP, Heikkila JJ, Bonen A. Differential effects of muscle contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle. J Physiol 573: 199-210, 2006.
5. Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, Isola L. Uptake of long chain fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 272: 8830-8835, 1997.
6. Berk PD, Zhou SL, Kiang CL, Stump D, Fan X, Bradbury M. Selective upregulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 274: 28626-28631, 1999.
7. Bezaire V, Bruce CR, Heigenhauser GJ, Tandon NN, Glatz JF, Luiken JJ, Bonen A, Spriet LL. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metab 290: E509-E515, 2006.
8. Binnert C, Koistinen HA, Martin G, Andreelli F, Ebeling P, Koivisto VA, Laville M, Auwerx J, Vidal H. Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans. Am J Physiol Endocrinol Metab 279: E1072-E1079, 2000.
9. Black PN, Dirusso CC. Yeast acyl-CoA synthetases at the crossroads of fatty acid metabolism and regulation. Biochim Biophys Acta. In press.
10. Bonen A, Campbell SE, Benton CR, Chabowski A, Coort SL, Han XX, Koonen D P, Glatz J F, Luiken JJ. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc 63: 245-249, 2004.
11. Bonen A, Dyck DJ, Ibrahimi A, Abumrad NA. Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am J Physiol Endocrinol Metab 276: E642-E649, 1999.
12. Bonen A, Elder GCB, Tan MH. Hindlimb suspension increases insulin binding and glucose metabolism. J Appl Physiol 65: 1833-1839, 1988.
13. Bonen A, Luiken JJFP, Arumugam Y, Glatz JFC, Tandon NN. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275: 14501-14508, 2000.
14. Bonen A, Luiken JJFP, Lui S, Dyck DJ, Kiens B, Kristiansen S, Turcotte L, van der Vusse GJ, Glatz JFC. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol Endocrinol Metab 275: E471-E478, 1998.
15. Bonen A, McDermott JC, Tan MH. Glycogenesis and glyconeogenesis in skeletal muscle: effects of pH and hormones. Am J Physiol Endocrinol Metab 258: E693-E700, 1990.
16. Bonen A, Miskovic D, Kiens B. Fatty acid transporters (FABPpm, FAT, FATP) in human muscle. Can J Appl Physiol 24: 515-523, 1999.
17. Bonen A, Miskovic D, Tonouchi M, Lemieux K, Wilson MC, Marette A, Halestrap AP. Abundance and subcellular distribution of MCT1 and MCT4 in heart and fast-twitch skeletal muscles. Am J Physiol Endocrinol Metab 278: E10667-E11077, 2000.
18. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JFC, Luiken JJFP, Heigenhauser GJF, Dyck DJ. Triacylglycerol accumulation in human obesity and Type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18: 1144-1146, 2004.
19. Bonen A, Tan MH. Dissociation between insulin binding and glucose utilization after intense exercise in mouse skeletal muscles. Horm Metab Res 21: 172-178, 1989.
20. Bonen A, Tan MH, Megeney LA, McDermott JC. Persistence of glucose metabolism after exercise in trained and untrained soleus muscle. Diabetes Care 15, Suppl 4: 1694-1700, 1992.
21. Bonen A, Tan MH, Watson-Wright WM. Effects of exercise on insulin binding and glucose metabolism in muscle. Can J Physiol Pharm 62: 1500-1504, 1984.
22. Bonen A, Tandon NN, Glatz J F, Luiken JJ, Heigenhauser GJ. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Int J Obes (Lond) 30: 877-883, 2006.
23. Bradbury MW, Berk PD. Mitochondrial aspartate aminotransferase: direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA. Biochem J 345: 423-427, 2000.
24. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, Hawley JA. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88: 5444-5451, 2003.
25. Cameron-Smith D, Burke LM, Angus DJ, Tunstall RJ, Cox GR, Bonen A, Hawley JA, Hargreaves M. A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. Am J Clin Nutr 77: 313-318, 2003.
26. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJFP, Glatz JFC, Bonen A. A novel function for FAT/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279: 36325-36341, 2004.
27. Chabowski A, Coort SL, Calles-Escandon J, Tandon NN, Glatz J F, Luiken JJ, Bonen A. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am J Physiol Endocrinol Metab 287: E781-E789, 2004.
28. Chabowski A, Coort SLM, Calles-Escandon J, Tandon NN, Glatz JFC, Luiken JJFP, Bonen A. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett 579: 2428-2432, 2005.
29. Chabowski A, Momken I, Coort SLM, Calles-Escandon J, Tandon NN, Glatz JFC, Luiken JJFP, Bonen A. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol Cell Biochem 288: 201-212, 2006.
30. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopa-thy. Circ Res 96: 225-233, 2005.
31. Clarke DC, Miskovic D, Han XX, Calles-Escandon J, Glatz JFC, Luiken JJFP, Heikkila JJ, Bonen A. Overexpression of membrane associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol Genomics 17: 31-37, 2004.
32. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissue of CD36 knockout mice. J Biol Chem 275: 32523-32529, 2000.
33. Coe NR, Smith AJ, Frohnert BI, Watkins PA, Bernlohr DA. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 274: 36300-36304, 1999.
34. Coort SL, Luiken JJ, Van Der Vusse GJ, Bonen A, Glatz J F. Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats. Biochem Soc Trans 32: 83-85, 2004.
35. Coort SLM, Hasselbaink DM, Koonen DYP, Willems J, Coumans WA, Chabowski A, van der Vusse GJ, Bonen A, Glatz JFC, Luiken JJFP. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes 53: 1655-1663, 2004.
36. Cupp D, Kampf J P, Kleinfeld AM. Fatty acid-albumin complexes and the determination of the transport of long chain free fatty acids across membranes. Biochemistry 43: 4473-4481, 2004.
37. Diede HE, Rodilla-Sala E, Gunawan J, Manns M, Stremmel W. Identification and characterization of a monoclonal antibody to the membrane fatty acid binding protein. Biochim Biophys Acta 1125: 13-20, 1992.
38. DiRusso CC, Li H, Darwis D, Watkins PA, Berger J, Black PN. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J Biol Chem 280: 16829-16837, 2005.
39. Doege H, Baillie RA, Ortegon AM, Tsang B, Wu Q, Punreddy S, Hirsch D, Watson N, Gimeno RE, Stahl A. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 130: 1245-1258, 2006.
40. Doege H, Stahl A. Protein-mediated fatty acid uptake: novel insights from in vivo models. Physiology 21: 259-268, 2006.
41. Dyck DJ, Bonen A. Muscle contraction increases palmitate esterification and oxidation, and triacyl-glycerol oxidation. Am J Physiol Endocrinol Metab 275: E888-E896, 1998.
42. Dyck DJ, Steinberg G, Bonen A. Insulin increases FFA uptake and esterification but reduces lipid utilization in isolated contracting muscles. Am J Physiol Endocrinol Metab 281: E600-E607, 2001.
43. Ehehalt R, Fullekrug J, Pohl J, Ring A, Herrmann T, Stremmel W. Translocation of long chain fatty acids across the plasma membrane: lipid rafts and fatty acid transport proteins. Mol Cell Biochem 284: 135-140, 2006.
44. Faergeman NJ, DiRusso CC, Elberger A, Knudsen J, Black PN. Disruption of the Saccharomyces cerevisiae homologue to the murine fatty acid transport protein impairs uptake and growth on long-chain fatty acids. J Biol Chem 272: 8531-8538, 1997.
45. Febbraio M, Abumrad NA, Hajjar D P, Sharma K, Cheng W, Frieda S, Pearce A, Silverstein RL. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274: 19055-19062, 1999.
46. Febbraio M, Hajjar D P, Silverstein RL. CD36: a class B scavenger receptor involved in angiogen-esis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791, 2001.
47. Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. Localization of adipocyte long-chain fatty acyl CoA synthetase at the plasma membrane. J Lipid Res 40: 881-892, 1999.
48. Gertow K, Pietilainen KH, Yki-Jarvinen H, Kaprio J, Rissanen A, Eriksson P, Hamsten A, Fisher RM. Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia 47: 1118-1125, 2004.
49. Gimeno RE, Hirsch DJ, Punreddy S, Sun Y, Ortegon AM, Wu H, Daniels T, Stricker-Krongrad A, Lodish H F, Stahl A. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J Biol Chem 278: 49512-49516, 2003.
50. Gimeno RE, Ortegon AM, Patel S, Punreddy S, Ge P, Sun Y, Lodish H F, Stahl A. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 278: 16039-16044, 2003.
51. Glatz JFC, Luiken J, Bonen A. Exercise and insulin increase muscle fatty acid uptake by recruiting putative fatty acid transporters to the sarcolemma. Curr Opin Clin Nutr Metab Care 5: 365-370, 2002.
52. Glatz JFC, Storch J. Unravelling the significance of cellular fatty acid binding proteins. Curr Opin Lipidol 12: 267-274, 2001.
53. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Ann Rev Med 49: 235-261, 1998.
54. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest 109: 1381-1389, 2002.
55. Hall AM, Smith AJ, Bernlohr DA. Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J Biol Chem 278: 43008-43013, 2003.
56. Hall AM, Wiczer BM, Herrmann T, Stremmel W, Bernlohr DA. Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase activities in tissues from FATP4 null mice. J Biol Chem 280: 11948-11954, 2005.
57. Hamilton J, Guo W, Kamp F. Mechanisms of cellular uptake of long-chain fatty acids: do we need cellular proteins? Mol Cell Biochem 239: 17-23, 2002.
58. Hamilton JA. Fatty acid transport: difficult or easy? J Lipid Res 39: 467-481, 1998.
59. Hamilton JA, Johnson RA, Corkey B, Kamp F. Fatty acid transport: the diffusion mechanism in model and biological membranes. J Mol Neurosci 16: 99-108; discussion 151-107, 2001.
60. Hamilton JA, Kamp F. How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes 48: 2255-2269, 1999.
61. Han XX, Chabowski A, Glatz JFC, Luiken JJFP, Bonen A. Fatty acid metabolism and FAT/CD36 translocation are resistant to insulin in skeletal muscle of obese Zucker rats. In: Keystone Symposium: Molecular Physiology and Genetics of the Control of Body Weight. Keystone, Colorado, 2005, p. 114.
62. Han XX, Febbraio M, Bonen A. Critical role of FAT/CD36 in regulating fatty acid metabolism in skeletal muscle. FASEB J: A1006, 2005.
63. Harmon CM, Abumrad NA. Binding of sulfosuc-cinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 133: 43-49, 1993.
64. Harmon CM, Luce P, Beth AH, Abumrad NA. Labeling of adipocyte membranes by sulfo-N-suc-cinimidyl derivatives of long-chain fatty acids: inhibition of fatty acid transport. J Membr Biol 121: 261-268, 1991.
65. Hatch GM, Smith AJ, Xu FY, Hall AM, Bernlohr DA. FATP1 channels exogenous FA into 1,2,3-tri-acyl-sn-glycerol and down-regulates sphin-gomyelin and cholesterol metabolism in growing 293 cells. J Lipid Res 43: 1380-1389, 2002.
66. Heinzer AK, Watkins PA, Lu J F, Kemp S, Moser AB, Li YY, Mihalik S, Powers JM, Smith KD. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystro-phy. Hum Mol Genet 12: 1145-1154, 2003.
67. Herrmann T, Grone HJ, Langbein L, Kaiser I, Gosch I, Bennemann U, Metzger D, Chambon P, Stewart A F, Stremmel W. Disturbed epidermal structure in mice with temporally controlled fatp4 deficiency. J Invest Dermatol 125: 1228-1235, 2005.
68. Herrmann T, van der Hoeven F, Grone HJ, Stewart A F, Langbein L, Kaiser I, Liebisch G, Gosch I, Buchkremer F, Drobnik W, Schmitz G, Stremmel W. Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show features of lethal restrictive dermopathy. J Cell Biol 161: 1105-1115, 2003.
69. Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med 13: 136-141, 2003.
70. Hirsch D, Stahl A, Lodish H F. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 95: 8625-8629, 1998.
71. Holloway G P, Bezaire V, Heigenhauser GJ, Tandon NN, Glatz J F, Luiken JJ, Bonen A, Spriet LL. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase 1 activity in human skeletal muscle during aerobic exercise. J Physiol 571: 201-210, 2006.
72. Hubbard B, Doege H, Punreddy S, Wu H, Huang X, Kaushik VK, Mozell RL, Byrnes JJ, Stricker-Krongrad A, Chou CJ, Tartaglia LA, Lodish H F, Stahl A, Gimeno RE. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology 130: 1259-1269, 2006.
73. Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K, Cameron R, Abumrad NA. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscles, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274: 26761-26766, 1999.
74. Ibrahimi A, Sfeir Z, Magharaine H, Amri EZ, Grimaldi P, Abumrad NA. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proc Natl Acad Sci USA 93: 2646-2651, 1996.
75. Irie H, Krukenkamp IB, Brinkmann J F, Gaudette GR, Saltman AE, Jou W, Glatz JF, Abumrad NA, Ibrahimi A. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci USA 100: 6819-6824, 2003.
76. Isola LM, Zhou SL, Kiang CL, Stump DD, Bradbury MW, Berk PD. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotrans-ferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake. Proc Natl Acad Sci USA 92: 9866-9870, 1995.
77. Johannsson E, McCullagh KJA, Han X, Fernando PK, Jensen J, Dahl HA, Bonen A. Effect of over-expressing GLUT-1 and GLUT-4 on insulin- and contraction stimulated glucose transport in muscle. Am J Physiol Endocrinol Metab 271: E547-E555, 1996.
78. Kampf J P, Cupp D, Kleinfeld AM. Different mechanisms of free fatty acid flip-flop and dissociation revealed by temperature and molecular species dependence of transport across lipid vesicles. J Biol Chem 281: 21566-21574, 2006.
79. Kampf J P, Kleinfeld AM. Fatty acid transport in adipocytes monitored by imaging intracellular free fatty acid levels. J Biol Chem 279: 35775-35780, 2004.
80. Kampf J P, Kleinfeld AM. Membrane transport of FFA mediated by lipid, protein, or both? Physiology 22: xxxx, 2006.
81. Kiens B, Kristiansen S, Jensen P, Richter EA, Turcotte L P. Membrane associated fatty acid binding protein (FABPpm) in human skeletal muscle is increased by endurance training. Biochem Biophys Res Comm 231: 463-465, 1997.
82. Kiens B, Roemen TH, van der Vusse GJ. Muscular long-chain fatty acid content during graded exercise in humans. Am J Physiol Endocrinol Metab 276: E352-E357, 1999.
83. Kim JK, Gimeno RE, Higashimori T, Kim HJ, Choi H, Punreddy S, Mozell RL, Tan G, Stricker-Krongrad A, Hirsch DJ, Fillmore JJ, Liu ZX, Dong J, Cline G, Stahl A, Lodish H F, Shulman GI. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 113: 756-763, 2004.
84. Kim YB, Shulman GI, Kahn BB. Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C? unknown symbol? but not on glycogen synthase kinase-3. J Biol Chem 277: 32915-32922, 2002.
85. King PA, Hirschman M F, Horton ED, Horton ES. Glucose transport in skeletal muscle membrane vesicles from control and exercised rats. Am J Physiol 257: C1128-C1134., 1989.
86. Koonen D P, Glatz J F, Bonen A, Luiken JJ. Long-chain fatty acid uptake and FAT/CD36 transloca-tion in heart and skeletal muscle. Biochim Biophys Acta 1736: 163-180, 2005.
87. Koonen DPY, Benton CR, Arumugam Y, Tandon NN, Calles-Escandon J, Glatz JFC, Luiken JJFP, Bonen A. Different mechanism can alter fatty acid transport when muscle contractile activity is chronically altered. Am J Physiol Endocrinol Metab 286: E1042-E1049, 2004.
88. Koonen DPY, Coumans WA, Arumugam Y, Bonen A, Glatz JFC, Luiken JJFP. Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism. Mol Cell Biochem 239: 121-130, 2002.
89. Kuang M, Febbraio M, Wagg C, Lopaschuk GD, Dyck JR. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation 109: 1550-1557, 2004.
90. Lauritzen H P, Ploug T, Prats C, Tavare JM, Galbo H. Imaging of insulin signaling in skeletal muscle of living mice shows major role of T-tubules. Diabetes 55: 1300-1306, 2006.
91. Lavrentyev EN, He D, Cook GA. Mistaken identity or yet another case of species difference? Am J Physiol Heart Circ Physiol 288: H448-H450, 2005.
92. Lemieux K, Han XX, Dombrowski L, Bonen A, Marette A. The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations. Diabetes 49: 183-189, 2000.
93. Luiken JJ, Coort SL, Koonen D P, van der Horst DJ, Bonen A, Zorzano A, Glatz J F. Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch 448: 1-15, 2004.
94. Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, Glatz J F. Dipyridamole alters cardiac substrate preference by inducing translocation of FAT/CD36, but not that of GLUT4. Mol Pharmacol 65: 639-645, 2004.
95. Luiken JJ, Willems J, Coort SL, Coumans WA, Bonen A, Van Der Vusse GJ, Glatz J F. Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes. Biochem J 367: 881-887, 2002.
96. Luiken JJFP, Arumugam Y, Dyck DJ, Bell RC, Pelsers ML, Turcotte L P, Tandon NN, Glatz JFC, Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276: 40567-40573, 2001.
97. Luiken JJFP, Coort SML, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JFC. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52: 1627-1634, 2003.
98. Luiken JJFP, Dyck DJ, Han XX, Tandon NN, Arumugam Y, Glatz JFC, Bonen A. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am J Physiol Endocrinol Metab 282: E491-E495, 2002.
99. Luiken JJFP, Koonen DPY, Coumans WA, Pelsers MMAL, Binas B, Bonen A, Glatz JFC. Long chain fatty acid uptake by skeletal muscles is impaired in homozygous, but not heterozygous, H-FABP null mice. Lipids 38: 491-496, 2003.
100. Luiken JJFP, Koonen DPY, Willems J, Zorzano A, Fischer Y, van der Vusse GJ, Bonen A, Glatz JFC. Insulin stimulates long-chain fatty acid uilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51: 3113-3119, 2002.
101. Luiken JJFP, Momken I, Habets D, Pelsers MMAL, Coumans WA, Koonen DPY, Glatz JFC, Bonen A. Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not of CD36 independent of MAPK signaling. Endocrinology. In press.
102. Luiken JJFP, Turcotte L P, Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 40: 1007-1016, 1999.
103. Luiken JJFP, Willems J, van der Vusse GJ, Glatz JFC. Electrostimulation enhances FAT/CD36-mediated long-chain fatty acid uptake by isolated rat cardiac myocytes. Am J Physiol Endocrinol Metab 281: E704-E712, 2001.
104. McCullagh KJA, Juel C, O'Brien M, Bonen A. Chronic muscle stimulation increases lactate transport in rat skeletal muscle. Mol Cell Biochem 156: 51-57, 1996.
105. McDermott JC, Bonen A. Lactate transport by skeletal muscle sarcolemmal vesicles. Mol Cell Biochem 122: 113-121, 1993.
106. McDermott JC, Bonen A. Lactate transport in rat sarcolemmal vesicles and intact skeletal muscle, and after muscle contraction. Acta Physiol Scand 151: 17-28, 1994.
107. Megeney LA, Neufer PD, Dohm GL, Tan MH, Blewett CA, Elder GCB, Bonen A. Effects of muscle activity and fiber composition on glucose transport and GLUT-4. Am J Physiol Endocrinol Metab 264: E583-E593, 1993.
108. Moulson CL, Martin DR, Lugus JJ, Schaffer JE, Lind AC, Miner JH. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc Natl Acad Sci USA 100: 5274-5279, 2003.
109. Muoio DM, Dohm GL, Fiedorek FT, Tapscott EB Jr, Coleman RA. Leptin directly alters lipid par-tioning in skeletal muscle. Diabetes 46: 1360-1363, 1997.
110. Muoio DM, Dohm GL, Tapscott EB, Coleman RA. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol Endocrinol Metab 276: E913-E921, 1999.
111. Nickerson J, Bonen A. Defining a role for skeletal muscle fatty acid transport proteins. In: 2nd Northern Lights Conference. Canadian Federation of Biological Societies. Guelph, Ontario, Canada: Canadian Federation of Biological Societies, 2005, p. F47.
112. Pei Z, Fraisl P, Berger J, Jia Z, Forss-Petter S, Watkins PA. Mouse very long-chain acyl-CoA syn-thetase3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells. J Biol Chem 279: 54454-54462, 2004.
113. Pohl J, Ring A, Korkmaz U, Ehehalt R, Stremmel W. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell 16: 24-31, 2005.
114. Rachek LI, Musiyenko SI, Ledoux SP, Wilson GL. Palmitate induced mtDNA damage and apoptosis in L6 rat skeletal muscle cells. Endocrinology. In press.
115. Ribarik Coe N, Johnston Smith A, Frohnert BI, Watkins PA, Bernlohr DA. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 274: 36300-36304, 1999.
116. Richards MR, Harp JD, Ory DS, Schaffer JE. Fatty acid transport protein 1 and long-chain acyl coen-zyme A synthetase 1 interact in adipocytes. J Lipid Res 47: 665-672, 2006.
117. Roepstorff C, Vistisen B, Roepstorff K, Kiens B. Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab 287: E696-E705, 2004.
118. Sakamoto K, Goodyear LJ. Invited review: intra-cellular signaling in contracting skeletal muscle. J Appl Physiol 93: 369-383, 2002.
119. Schaffer JE, Lodish H F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79: 427-436, 1994.
120. Schenk S, Horowitz J F. Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training. Am J Physiol Endocrinol Metab 291: E254-E260, 2006.
121. Schwieterman W, Sorrentino D, Potter BJ, Rand J, Kiang CL, Stump D, Berk PD. Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc Natl Acad Sci USA 85: 359-363, 1988.
122. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon G P, Frazier OH, Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18: 1692-1700, 2004.
123. Smith AC, Bruce CR, Dyck DJ. AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle. J Physiol 565: 547-553, 2005.
124. Smith AC, Bruce CR, Dyck DJ. AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle. J Physiol 565: 537-546, 2005.
125. Spitsberg VL, Matitashvili E, Gorewit RC. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland. Eur J Biochem 230: 872-878, 1995.
126. Stahl A. A current review of fatty acid transport proteins (SLC27). Pflugers Arch 447: 722-727, 2003.
127. Stahl A, Evans JG, Pattel S, Hirsch D, Lodish H F. Insulin causes fatty acid transport protein translo-cation and enhanced fatty acid uptake in adipocytes. Dev Cell 2: 477-488, 2002.
128. Stahl A, Hirsch DJ, Gimeno RE, Punreddy S, Ge P, Watson N, Patel S, Kotler M, Raimondi A, Tartaglia LA, Lodish H F. Identification of the major intestinal fatty acid transport protein. Mol Cell 4: 299-308, 1999.
129. Steinberg GR, Dyck DJ, Calles-Escandon J, Tandon NN, Luiken JJFP, Glatz J F, Bonen A. Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J Biol Chem 277: 8854-8860, 2002.
130. Steinberg GR, Parolin ML, Heigenhauser GJF, Dyck DJ. Leptin increases fatty acid oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-E192, 2002.
131. Stremmel W. Fatty acid uptake by isolated heart myocytes represents a carier-mediated transport process. J Clin Invest 81: 844-852, 1988.
132. 14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc Natl Acad Sci USA 83: 3086-3090, 1986.
133. Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci USA 82: 4-8, 1985.
134. Stump DD, Zhou SL, Berk PD. Comparison of plasma membrane FABP and mitochondrial iso-form of aspartate aminotransferase from rat liver. Am J Physiol Gastrointest Liver Physiol 265: G894-G902, 1993.
135. Summers SA, Garza LA, Zhou H, Birnbaum MJ. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18: 5457-5464, 1998.
136. Tong F, Black PN, Coleman RA, DiRusso CC. Fatty acid transport by vectorial acylation in mammals: roles played by different isoforms of rat long-chain acyl-CoA synthetases. Arch Biochem Biophys 447: 46-52, 2006.
137. Tunstall RJ, Mehan KA, Wadley GD, Collier GR, Bonen A, Hargreaves M, Cameron-Smith D. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283: E66-E72, 2002.
138. Turcotte L P, Raney MA, Todd MK. ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle. Acta Physiol Scand 184: 131-139, 2005.
139. Turcotte L P, Swenberger JR, Tucker MZ, Trump G, Yee AJ, Luiken JJFP, Bonen A. Muscle palmitate transport and binding are saturable and inhibited by antibodies to FABPpm. Mol Cell Biochem 210: 53-63, 2000.
140. Turcotte L P, Swenberger JR, Tucker MZ, Yee AJ. Training-induced elevation in FABPpm is associated with increased palmitate use in contracting muscle. J Appl Physiol 87: 285-293, 1999.
141. van der Vusse GJ, Roemen THM. Gradient of fatty acids from blood plasma to skeletal muscle in dogs. J Appl Physiol 78: 1839-1843, 1995.
142. Watkins PA, Lu J F, Steinberg SJ, Gould SJ, Smith KD, Braiterman LT. Disruption of the Saccharomyces cerevisiae FAT1 gene decreases very long-chain fatty acyl-CoA synthetase activity and elevates intracellular very long-chain fatty acid concentrations. J Biol Chem 273: 18210-18219, 1998.
143. Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 26: 3455-3467, 2006.
144. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GW, Atcheson B, White MF, Kraegen EW, Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.
145. Zou Z, Tong F, Faergeman NJ, Borsting C, Black PN, DiRusso CC. Vectorial acylation in Saccharomyces cerevisiae. Fat1p and fatty acyl-CoA synthetase are interacting components of a fatty acid import complex. J Biol Chem 278: 16414-16422, 2003.